78 related articles for article (PubMed ID: 22933074)
1. Effect of genetic background on the contribution of New Zealand black loci to autoimmune lupus nephritis.
Rozzo SJ; Vyse TJ; Drake CG; Kotzin BL
Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15164-8. PubMed ID: 8986781
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.
Daamen AR; Wang H; Bachali P; Shen N; Kingsmore KM; Robl RD; Grammer AC; Fu SM; Lipsky PE
Front Immunol; 2023; 14():1147526. PubMed ID: 36936908
[TBL] [Abstract][Full Text] [Related]
3. Application of nanotechnology in the treatment of glomerulonephritis: current status and future perspectives.
Zhan HQ; Zhang X; Chen XL; Cheng L; Wang X
J Nanobiotechnology; 2024 Jan; 22(1):9. PubMed ID: 38169389
[TBL] [Abstract][Full Text] [Related]
4. Animal models of lupus nephritis: the past, present and a future outlook.
Katikaneni D; Morel L; Scindia Y
Autoimmunity; 2024 Dec; 57(1):2319203. PubMed ID: 38477884
[TBL] [Abstract][Full Text] [Related]
5. Mouse models of lupus: what they tell us and what they don't.
Richard ML; Gilkeson G
Lupus Sci Med; 2018; 5(1):e000199. PubMed ID: 29387435
[TBL] [Abstract][Full Text] [Related]
6. Molecular and Immunological Basis of Tubulo-Interstitial Injury in Lupus Nephritis: a Comprehensive Review.
Yung S; Chan TM
Clin Rev Allergy Immunol; 2017 Apr; 52(2):149-163. PubMed ID: 26961386
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.
Chirico V; Lacquaniti A; Salpietro V; Munafò C; Calabrò MP; Buemi M; Arrigo T; Salpietro C
Eur J Pediatr; 2014 Sep; 173(9):1123-36. PubMed ID: 24809802
[TBL] [Abstract][Full Text] [Related]
8. Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage.
Bagavant H; Deshmukh US; Gaskin F; Fu SM
Scand J Immunol; 2004; 60(1-2):52-63. PubMed ID: 15238073
[TBL] [Abstract][Full Text] [Related]
9. Tubulointerstitial nephritis in systemic lupus erythematosus: innocent bystander or ominous presage.
Dhingra S; Qureshi R; Abdellatif A; Gaber LW; Truong LD
Histol Histopathol; 2014 May; 29(5):553-65. PubMed ID: 24288339
[TBL] [Abstract][Full Text] [Related]
10. Genetic approach to study lupus glomerulonephritis.
Ge Y; Brown MG; Wang H; Fu SM
Methods Mol Biol; 2012; 900():271-90. PubMed ID: 22933074
[TBL] [Abstract][Full Text] [Related]
11. NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci.
Waters ST; Fu SM; Gaskin F; Deshmukh US; Sung SS; Kannapell CC; Tung KS; McEwen SB; McDuffie M
Clin Immunol; 2001 Sep; 100(3):372-83. PubMed ID: 11513551
[TBL] [Abstract][Full Text] [Related]
12. Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis.
Ge Y; Jiang C; Sung SS; Bagavant H; Dai C; Wang H; Kannapell CC; Cathro HP; Gaskin F; Fu SM
J Exp Med; 2013 Oct; 210(11):2387-401. PubMed ID: 24101379
[TBL] [Abstract][Full Text] [Related]
13. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis.
Waters ST; McDuffie M; Bagavant H; Deshmukh US; Gaskin F; Jiang C; Tung KS; Fu SM
J Exp Med; 2004 Jan; 199(2):255-64. PubMed ID: 14718514
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune experimental orchitis and chronic glomerulonephritis with end stage renal disease are controlled by Cgnz1 for susceptibility to end organ damage.
Zhao Z; Qiao H; Ge Y; Kannapel CC; Sung SJ; Gaskin F; Tung KSK; Fu SM
Clin Immunol; 2021 Mar; 224():108675. PubMed ID: 33482358
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
